Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels
Authors:
- Clifford J. HolmesCHClifford J. Holmes
- Raymond T. KredietRKRaymond T. Krediet
- Ruth MackenzieRMRuth Mackenzie
- Dirk FaictDFDirk Faict
- Anders TranaeusATAnders Tranaeus
- John D. WilliamsJWJohn D. Williams
- Gerald A. ColesGCGerald A. Coles
- Nicholas TopleyNTNicholas Topley
- on behalf of the BICARBONATE/LACTATE STUDY GROUPOGon behalf of the BICARBONATE/LACTATE STUDY GROUP
- 1 April 2001
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 59 (4) , 1529-1538
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- In vivo exposure to bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage functionAmerican Journal of Kidney Diseases, 2000
- Carboxyterminal propeptide of type I procollagen in ELF: elevation in asbestosis, but not in pleural plaque diseaseEuropean Respiratory Journal, 1999
- Growth Factors in Continuous Ambulatory Peritoneal Dialysis EffluentAmerican Journal of Nephrology, 1999
- What really happens to people on long-term peritoneal dialysis?Kidney International, 1998
- Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitisNephrology Dialysis Transplantation, 1996
- Fibrosis linked to TGF-beta in yet another disease.Journal of Clinical Investigation, 1995
- The source and possible significance of hyaluronan in the peritoneal cavityKidney International, 1994
- CA 125 secretion by peritoneal mesothelial cells.Journal of Clinical Pathology, 1994
- Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysisKidney International, 1992
- Peritoneal Morphology on Maintenance DialysisAmerican Journal of Nephrology, 1989